>
Ethiopians Brew Success as Coffee and Cash Pile Up Thanks to Transformational Sustainable...
Apocalyptic 'wall of dust' engulfs Chicago as at least 23 are killed and half a million are.
Kennedy Faces Insufferable Congressmen
Trump Skewers Neoconservative Interventionist Foreign Policy
Watch: Jetson's One Aircraft Just Competed in the First eVTOL Race
Cab-less truck glider leaps autonomously between road and rail
Can Tesla DOJO Chips Pass Nvidia GPUs?
Iron-fortified lumber could be a greener alternative to steel beams
One man, 856 venom hits, and the path to a universal snakebite cure
Dr. McCullough reveals cancer-fighting drug Big Pharma hopes you never hear about…
EXCLUSIVE: Raytheon Whistleblower Who Exposed The Neutrino Earthquake Weapon In Antarctica...
Doctors Say Injecting Gold Into Eyeballs Could Restore Lost Vision
"Technocracy is the science of social engineering," says Patrick Wood, author of Technocracy Rising.
Social engineering used to mean molding the minds of people to conform to new norms. This goes back to 1928, Ed Bernays, and his book Propaganda. However, in a Technocracy, not only minds, but bodies, too, can be molded. If you did not get the memo, Technocracy has brought humanity from Human to Posthuman and Transhuman.
In the 2022 Journal Global Trends, Russian scientists describe the difference between Posthuman and Transhuman:
The fundamental idea of posthumanism is the rejection of biological, ethical, and ontological anthropocentrism. Transhumanism focuses on changing and improving natural human characteristics through biological, technological, and cognitive modifications…Transhumanism has the potential to preserve man as an effective economic and cognizing agent.
In other words, man as an "economic agent" refers to the cybernetic human as a commodity in a modern world. This means the laws of the nations need to change to catch up.
The U.S. FDA is meeting that goal for change with its FDA Modernization Act 2.0. What is the FDA Modernization Act 2.0?
The new law amends the Federal Food, Drug, and Cosmetic Act by authorizing sponsors of novel drugs to make use of "certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.